what is a glp 1 ra Consensus Recommendations on GLP-1 Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy The Role of GLP-1RA Medications

Acknowledgements Review criteria Relevant studies were identified through PubMed and Google Scholar searches up to June 2025 using combinations of the terms diabetes mellitus, thyroid dysfunction, hypothyroidism, hyperthyroidism, obesity, autoimmunity and non-communicable diseases

External resources SURMOUNT-5 Trial: Tirzepatide vs Semaglutide for Obesity (NEJM) STEP 1 Trial: Semaglutide 2.4 mg for Weight Management (NEJM) For researchers serious about optimizing their weight management protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based dosing guides, personalized protocol builders, and a community of thousands who have navigated these exact dosing decisions

A.EdwardsC

And most importantly, thanks for all of you out there listening

These include: Increased appetite and food cravings , which may work against Wegovy's appetite-suppressing effects Insulin resistance and elevated blood glucose levels , potentially leading to steroid-induced diabetes Fluid retention and weight gain , particularly in the face, neck, and trunk (cushingoid features) Redistribution of body fat to central areas Muscle wasting , which can reduce metabolic rate Patients taking both medications may experience reduced weight loss efficacy compared to those taking Wegovy alone, though the appetite-suppressing effects of Wegovy may help mitigate steroid-induced hunger